• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    38 Stocks Moving In Thursday's Mid-Day Session

    4/7/22 1:14:13 PM ET
    $ADN
    $APTX
    $AUR
    $BBAI
    Industrial Machinery/Components
    Miscellaneous
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADN alert in real time by email

    Gainers

    • MedAvail Holdings, Inc. (NASDAQ:MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.
    • Momentus Inc. (NASDAQ:MNTS) shares jumped 48.4% to $4.3786 as the company signed multiple launch agreements with Space Exploration Technologies Corp. (SpaceX), a Tesla CEO Elon Musk-led company.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) surged 37.2% to $8.63. Sunshine Biopharma recently announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
    • System1, Inc. (NYSE:SST) gained 26.5% to $25.30. The company on Monday reported Q4 and FY22 financials results.
    • Werewolf Therapeutics, Inc. (NASDAQ:HOWL) jumped 23.5% to $5.84 after the company and Jazz Pharmaceuticals announced an exclusive global license and collaboration agreement to develop WTX-613, a differentiated, conditionally-activated IFNα INDUKINE molecule.
    • MiNK Therapeutics, Inc. (NASDAQ:INKT) jumped 20.6% to $2.92.
    • Ikena Oncology, Inc. (NASDAQ:IKNA) gained 19% to $6.63.
    • Sprinklr, Inc. (NYSE:CXM) jumped 17.2% to $13.35 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 and FY23 sales guidance above analyst estimates.
    • Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) gained 16.1% to $3.53.
    • HP Inc. (NYSE:HPQ) rose 15.7% to $40.38 following a Form 4 filing from Berkshire Hathaway's Warren Buffett which showed the purchase of approximately 11.1 million shares of the company's stock.
    • Origin Agritech Limited (NASDAQ:SEED) shares gained 11.4% to $8.13 after the company announced it has signed purchase agreements to sell two feedstock companies a total 50,000 metric tons of its corn for RMB150 million.
    • CDK Global, Inc. (NASDAQ:CDK) gained 11.4% to $54.57 after the company announced it will be acquired by Brookfield for $54.87 per share in cash.
    • BigBear.ai Holdings, Inc. (NYSE:BBAI) jumped 10.6% to $11.47 amid continued retail investor interest.
    • NeoGenomics, Inc. (NASDAQ:NEO) gained 10.6% to $12.71.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 9.4% to $1.4005 after the company announced it has harmonized its miRNA Whole Transcriptome Assay with the HTG Transcriptome Panel.
    • Conduent Incorporated (NASDAQ:CNDT) gained 9.2% to $5.30 after the company announced it is pursuing a separation of its Transportation business through either a sale or a spin-off.
    • Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) jumped 8.8% to $6.95.
    • Euronav NV (NASDAQ:EURN) rose 5.3% to $11.82 after the company announced a stock-for-stock combination with Frontline.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Blue Water Vaccines, Inc. (NYSE:BWV) shares fell 73.5% to $15.67.
    • Aptinyx Inc. (NASDAQ:APTX) shares tumbled 48.8% to $1.1999 after the company reported results from its Phase 2b study of NYX-2925 in painful diabetic peripheral neuropathy. The company reported NYX-2925 did not achieve the primary endpoint of the study.
    • GWG Holdings, Inc. (NASDAQ:GWGH) dropped 41.2% to $1.54.
    • Vapotherm, Inc. (NYSE:VAPO) fell 33.8% to $8.56 after the company announced the withdrawal of FY22 guidance and issued Q1 sales guidance below analyst estimates.
    • Integrated Media Technology Limited (NASDAQ:IMTE) dipped 33% to $13.75.
    • Nutex Health Inc. (NASDAQ:NUTX) dropped 29.4% to $12.63.
    • Rite Aid Corporation (NYSE:RAD) fell 23.4% to $6.47 after Deutsche Bank downgraded the stock from Hold to Sell and lowered its price target from $16 to $1.
    • Canaan Inc. (NASDAQ:CAN) dropped 19.9% to $4.88 amid a drop in Bitcoin prices, which has pressured crypto-related stocks.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 18.8% to $2.46.
    • Lilium N.V. (NASDAQ:LILM) dropped 17.6% to $4.0375.
    • Biophytis SA (NASDAQ:BPTS) fell 17.4% to $2.1487 after the company issued updates on Sarconeos (BIO101) clinical development.
    • Aurora Innovation, Inc. (NASDAQ:AUR) dropped 16.7% to $4.7191.
    • Moxian (BVI) Inc (NASDAQ:MOXC) shares fell 14.7% to $1.98 after jumping 40% on Wednesday.
    • iQIYI, Inc. (NASDAQ:IQ) dropped 14% to $4.5250 amid lockdown measures in Shanghai as COVID-19 cases in China rise.
    • Advent Technologies Holdings, Inc. (NASDAQ:ADN) fell 13% to $3.1599. Advent Technologies recently announced a definitive agreement with Hyundai Motor Company to use fuel cell technology in delivering green energy solutions to current high carbon applications.
    • VNET Group, Inc. (NASDAQ:VNET) fell 13% to $5.57 amid lockdown measures in Shanghai as COVID-19 cases in China rise.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) declined 12.4% to $18.96 amid continued concerns over aggressive Fed tapering in order to curb inflation. The Russia-Ukraine conflict and a COVID-19 surge in China have also pressured global macro sentiment.
    • CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCCS) shares fell 10.2% to $9.60 after the company reported pricing of secondary offering of common stock by selling stockholders.
    • IronNet, Inc. (NASDAQ:IRNT) fell 8.9% to $3.2601 after the company reported worse-than-expected preliminary Q4 EPS results.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) shares fell 8.7% to $3.58. Pulse Biosciences recently reported worse-than-expected Q4 EPS and sales results.
    Get the next $ADN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADN
    $APTX
    $AUR
    $BBAI

    CompanyDatePrice TargetRatingAnalyst
    HP Inc.
    $HPQ
    2/3/2026$20.00Neutral → Underperform
    BofA Securities
    Pulse Biosciences Inc
    $PLSE
    1/30/2026$25.00Outperform
    Mizuho
    HP Inc.
    $HPQ
    1/16/2026$18.00Equal Weight → Underweight
    Barclays
    HP Inc.
    $HPQ
    1/13/2026$21.00Sell
    Goldman
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Werewolf Therapeutics Inc.
    $HOWL
    12/19/2025$1.00Outperform → Neutral
    Wedbush
    Canaan Inc.
    $CAN
    12/8/2025$3.00Buy
    BTIG Research
    Black Diamond Therapeutics Inc.
    $BDTX
    12/3/2025Buy → Neutral
    Guggenheim
    More analyst ratings

    $ADN
    $APTX
    $AUR
    $BBAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Iveda Announces Pricing of $2 Million Public Offering

    MESA, Ariz., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Iveda® (NASDAQ:IVDA), the global leader in AI video surveillance and smart city solutions, today announced the pricing of a public offering of 5,714,286 shares of its common stock (or pre-funded warrants in lieu thereof) and series X warrants to purchase up to 11,428,572 shares of its common stock, at a combined public offering price of $0.35 per share (or pre-funded warrant in lieu thereof) and accompanying series X warrants. The series X warrants will have an exercise price of $0.35 per share, will be exercisable immediately upon issuance and will expire two years from the date of issuance. The closing of the offering is expected to occur on

    2/9/26 8:23:00 PM ET
    $IVDA
    Computer Software: Prepackaged Software
    Technology

    Momentus and NASA Partner to Advance In-Orbit Servicing and Space Operations

    A groundbreaking mission to advance in-orbit servicing, rendezvous and proximity operations, and space infrastructure development in low Earth orbit. Momentus Inc. (NASDAQ:MNTS), a commercial space firm specializing in satellite solutions and in-space infrastructure, has entered into a Space Act Agreement to deepen its collaboration with the National Aeronautics and Space Administration (NASA) through a groundbreaking mission set to advance in-orbit servicing and assembly capabilities. Under this initiative, Momentus will deliver a NASA CubeSat to low Earth orbit (LEO) to demonstrate joint rendezvous and proximity operations (RPO) as well as formation flying. Central to the mission is N

    2/9/26 8:00:00 AM ET
    $MNTS
    Military/Government/Technical
    Industrials

    HP Inc. Sets Annual Meeting and Record Dates

    PALO ALTO, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- The HP Inc. (NYSE:HPQ) board of directors has established a record date for its 2026 annual meeting of stockholders. HP Inc.'s stockholders of record at the close of business on February 17, 2026 will be entitled to notice of the annual meeting and to vote upon matters considered at the meeting. The annual meeting is scheduled to be held on April 16, 2026. HP Inc. will make available to all stockholders of record important information about the meeting and the matters to be considered. Stockholders are urged to review that information when it becomes available. About HP Inc.HP Inc. (NYSE:HPQ) is a global technology leader redefining th

    2/6/26 6:30:00 PM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ADN
    $APTX
    $AUR
    $BBAI
    SEC Filings

    View All

    SEC Form 424B5 filed by Momentus Inc.

    424B5 - Momentus Inc. (0001781162) (Filer)

    2/9/26 5:17:22 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form 424B5 filed by Momentus Inc.

    424B5 - Momentus Inc. (0001781162) (Filer)

    2/6/26 4:53:27 PM ET
    $MNTS
    Military/Government/Technical
    Industrials

    SEC Form 8-K filed by Werewolf Therapeutics Inc.

    8-K - Werewolf Therapeutics, Inc. (0001785530) (Filer)

    2/6/26 4:41:00 PM ET
    $HOWL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADN
    $APTX
    $AUR
    $BBAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Read Rory P bought $152 worth of shares (20 units at $7.60) and sold $996,726 worth of shares (165,858 units at $6.01), decreasing direct ownership by 10% to 1,506,270 units (SEC Form 4)

    4 - Sprinklr, Inc. (0001569345) (Issuer)

    2/9/26 5:00:05 PM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Bates Jon Christian bought $102,532 worth of shares (750 units at $136.71), increasing direct ownership by 15% to 5,638 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    11/28/25 2:11:24 PM ET
    $NUTX
    Real Estate

    Chief Executive Officer Urmson Christopher bought $1,000,627 worth of shares (258,000 units at $3.88) (SEC Form 4)

    4 - Aurora Innovation, Inc. (0001828108) (Issuer)

    11/26/25 9:09:12 AM ET
    $AUR
    EDP Services
    Technology

    $ADN
    $APTX
    $AUR
    $BBAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HP Inc. downgraded by BofA Securities with a new price target

    BofA Securities downgraded HP Inc. from Neutral to Underperform and set a new price target of $20.00

    2/3/26 10:06:05 AM ET
    $HPQ
    Computer Manufacturing
    Technology

    Mizuho initiated coverage on Pulse Biosciences with a new price target

    Mizuho initiated coverage of Pulse Biosciences with a rating of Outperform and set a new price target of $25.00

    1/30/26 6:44:12 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    HP Inc. downgraded by Barclays with a new price target

    Barclays downgraded HP Inc. from Equal Weight to Underweight and set a new price target of $18.00

    1/16/26 8:29:55 AM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ADN
    $APTX
    $AUR
    $BBAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Read Rory P bought $152 worth of shares (20 units at $7.60) and sold $996,726 worth of shares (165,858 units at $6.01), decreasing direct ownership by 10% to 1,506,270 units (SEC Form 4)

    4 - Sprinklr, Inc. (0001569345) (Issuer)

    2/9/26 5:00:05 PM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:04:42 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:01:09 PM ET
    $NUTX
    Real Estate

    $ADN
    $APTX
    $AUR
    $BBAI
    Leadership Updates

    Live Leadership Updates

    View All

    Conduent Appoints Harsha V. Agadi as Chief Executive Officer

    Succeeds Cliff Skelton, who will step down as President and CEO Margarita Paláu-Hernández appointed independent Chair of the Board Conduent Incorporated (NASDAQ:CNDT), a global technology-driven business solutions and services company, today announced that the Board of Directors has appointed Harsha V. Agadi, Chairman of Conduent's Board of Directors, as Chief Executive Officer, effective immediately. As part of this transition, Mr. Agadi will step down as Chairman of the Board, and Margarita Paláu-Hernández has been appointed independent Chair of the Board. Mr. Agadi succeeds Cliff Skelton, who will step down as President, Chief Executive Officer, and a member of the Board of Directors

    1/16/26 4:30:00 PM ET
    $CNDT
    Real Estate

    NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

    – Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 million – – Announces Chief Financial Officer transition – NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced preliminary fourth quarter and full-year 2025 revenue and also announced a transition of the Company's Chief Financial Officer. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue For the fourth quarter of 2025, NeoGenomics expects to report total revenue of approximately $190 million, representing year-over-year growth of 11%. For the full-year 2025, Neo

    1/12/26 7:05:00 AM ET
    $NEO
    Precision Instruments
    Health Care

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    $ADN
    $APTX
    $AUR
    $BBAI
    Financials

    Live finance-specific insights

    View All

    Conduent to Report Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 12, 2026

    Conduent Incorporated (NASDAQ:CNDT), a global technology-driven business solutions and services company, plans to report its fourth-quarter and full-year 2025 financial results on Thursday, February 12 before market open. Management will present the results during a conference call and webcast at 9:00 a.m. ET. The call will be available by live audiocast along with the news release and online presentation slides at https://investor.conduent.com/. The conference call will also be available by calling 877-407-4019 toll free. If requested, the conference ID is 13758159. The international dial-in is +1 201-689-8337. The international conference ID is also 13758159. A recording of the co

    2/6/26 9:15:00 AM ET
    $CNDT
    Real Estate

    Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 from the U.S. or 1-646-307-1963 internationally and providing Conference ID 7647402. A live and recorded webcast of the event will be available on the Pulse Bioscie

    2/4/26 4:05:00 PM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    HP Inc. to Announce First Quarter Fiscal 2026 Earnings on Feb 24, 2026

    PALO ALTO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) will present a live audio webcast of a conference call to review financial results for the first fiscal quarter ended January 31, 2026 on Tuesday, Feb 24, 2026 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be available at www.hp.com/investor/2026Q1Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more tha

    2/3/26 7:00:02 AM ET
    $HPQ
    Computer Manufacturing
    Technology

    $ADN
    $APTX
    $AUR
    $BBAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/10/24 4:15:32 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology